Science Corporation acquired the retinal implant technology from French medical device company Pixium Vision, rescuing the project and enabling continued clinical trials. The acquisition was reported as having occurred in 2024 after Pixium ran out of funding.
Comments
Want to join the conversation?
Loading comments...